Literature DB >> 20501775

Active and passive smoking and the risk of pancreatic cancer in the Netherlands Cohort Study.

Mirjam M Heinen1, Bas A J Verhage, R Alexandra Goldbohm, Piet A van den Brandt.   

Abstract

BACKGROUND: To date, cigarette smoking is the most consistent risk factor for pancreatic cancer. We prospectively examined the role of active cigarette smoking, smoking cessation, and passive smoking as determinants for pancreatic cancer.
METHODS: The Netherlands Cohort Study consisted of 120,852 men and women who completed a baseline questionnaire in 1986. After 16.3 years of follow-up, 520 incident pancreatic cancer cases were available for analysis. A case-cohort approach was employed using the person-years of follow-up of a random subcohort (n = 5,000), which was chosen immediately after baseline.
RESULTS: Compared with never cigarette smokers, both former and current cigarette smokers had an increased pancreatic cancer risk [multivariable-adjusted hazard rate ratio (HR), 1.34; 95% confidence interval (CI), 1.02-1.75 and HR, 1.82; 95% CI, 1.40-2.38, respectively]. We observed an increased pancreatic cancer risk per increment of 10 years of smoking (HR, 1.15; 95% CI, 1.08-1.22) and an HR of 1.08 per increment of 10 cigarettes/d (95% CI, 0.98-1.19). Quitting smoking gradually reduced pancreatic cancer risk and approached unity after > or = 20 years of quitting. No association was observed for passive smoking exposure and pancreatic cancer risk in women; in men, this association was not investigated because >90% of the men were ever smokers.
CONCLUSIONS: Overall, our findings confirmed that cigarette smoking is an important risk factor for pancreatic cancer, whereas quitting smoking reduced risk. No association was observed between passive smoking exposure and pancreatic cancer risk in women. IMPACT: Quitting smoking would benefit the burden on pancreatic cancer incidence. Copyright 2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20501775     DOI: 10.1158/1055-9965.EPI-10-0121

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  8 in total

1.  Genetic variants in carcinogen-metabolizing enzymes, cigarette smoking and pancreatic cancer risk.

Authors:  Ji-Hyun Jang; Michelle Cotterchio; Ayelet Borgida; Steven Gallinger; Sean P Cleary
Journal:  Carcinogenesis       Date:  2012-02-02       Impact factor: 4.944

2.  Polymorphisms in metabolism/antioxidant genes may mediate the effect of dietary intake on pancreatic cancer risk.

Authors:  Rick J Jansen; Dennis P Robinson; Rachael Z Stolzenberg-Solomon; William R Bamlet; XiangLin Tan; Julie M Cunningham; Ying Li; David N Rider; Ann L Oberg; Kari G Rabe; Kristin E Anderson; Rashmi Sinha; Gloria M Petersen
Journal:  Pancreas       Date:  2013-10       Impact factor: 3.327

3.  Pancreatic cancer: why is it so hard to treat?

Authors:  Paul E Oberstein; Kenneth P Olive
Journal:  Therap Adv Gastroenterol       Date:  2013-07       Impact factor: 4.409

Review 4.  Epidemiology of pancreatic cancer and the role of family history.

Authors:  Sara H Olson; Robert C Kurtz
Journal:  J Surg Oncol       Date:  2012-05-15       Impact factor: 3.454

5.  Proton pump inhibitors and histamine-2-receptor antagonists and pancreatic cancer risk: a nested case-control study.

Authors:  M C Bradley; L J Murray; M M Cantwell; C M Hughes
Journal:  Br J Cancer       Date:  2011-11-22       Impact factor: 7.640

6.  Association between alcohol consumption and pancreatic cancer risk: a case-control study.

Authors:  Farah Rahman; Michelle Cotterchio; Sean P Cleary; Steven Gallinger
Journal:  PLoS One       Date:  2015-04-09       Impact factor: 3.240

7.  Exposure to Secondhand Smoke and Risk of Cancer in Never Smokers: A Meta-Analysis of Epidemiologic Studies.

Authors:  A-Sol Kim; Hae-Jin Ko; Jin-Hyun Kwon; Jong-Myung Lee
Journal:  Int J Environ Res Public Health       Date:  2018-09-11       Impact factor: 3.390

8.  Risk factors of Pancreatic Cancer in Vietnam: A Matched Case-Control Hospital-Based Study.

Authors:  Thuan Van Tran; Tu Van Dao; Khac-Dung Nguyen; To van Ta; Khanh Truong Vu; Son Hong Trinh; Hoang Cong Nguyen; Oanh Thi Bui; Quang Tien Nguyen; Hoan Duc Vu; Hiep Le Nguyen; Huong Thanh Tran
Journal:  Cancer Control       Date:  2021 Jan-Dec       Impact factor: 3.302

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.